About this trial
To demonstrate the potential benefits and risk of active sub-threshold stimulation in the treatment of chronic knee pain as compared to subjects that did not have active stimulation. Improvement will be assessed in relation to the clinical outcome measures of pain, with primary endpoint; Pain relief rate as measured by the number of subjects with greater or equal to a 50% decrease in pain on the visual analog scale, comparing baseline to the 1-month follow-up.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Wireless neuromodulation
Treatment groups
Sponsors and collaborators
Curonix LLC
Lead sponsor
Texas Institute for Pain and spine
Collaborator
Performance Pain and Sports Medicine PLLC
Collaborator
Holy Cross Hospital, Inc
Collaborator
Colorado pain Care, LLC
Collaborator
Advanced Spine and Pain
Collaborator
Desert Orthopaedic Institute
Collaborator
Vista Clinical Research
Collaborator
Premier Pain Treatment
Collaborator
Florida Joint Pain Institute
Collaborator
Austin Orthopedic Institute
Collaborator
Kettering Health
Collaborator